Drug Type Bispecific antibody |
Synonyms CA9 PMTE, CA9PMTE |
Target |
Mechanism CAIX inhibitors(Carbonic anhydrase IX inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Clear Cell Renal Cell Carcinoma | Preclinical | US | 04 Jun 2024 | |
Locally Advanced Clear Cell Renal Cell Carcinoma | Preclinical | US | 04 Jun 2024 |